Michael Pawlita
Prevalence of Transcriptionally Active HPV Infection in Tumor-Free Oropharyngeal Tissue of OPSCC-Patients.
Guarda V, Schroeder L, Pawlita M, Ikenberg K, Rupp N, Jochum W, Stoeckli S, Holzinger D, Broglie M. Prevalence of Transcriptionally Active HPV Infection in Tumor-Free Oropharyngeal Tissue of OPSCC-Patients. Front Oncol 2022; 12:835814.
22.04.2022Prevalence of Transcriptionally Active HPV Infection in Tumor-Free Oropharyngeal Tissue of OPSCC-Patients.
22.04.2022Front Oncol 2022; 12:835814
Guarda Vittoria, Schroeder Lea, Pawlita Michael, Ikenberg Kristian, Rupp Niels J, Jochum Wolfram, Stoeckli Sandro J, Holzinger Dana, Broglie Martina A
Evaluation of type-specific antibodies to high risk-human papillomavirus (HPV) proteins in patients with oropharyngeal cancer
Broglie Däppen M, Jochum W, Michel A, Waterboer T, Foerbs D, Schoenegg R, Stöckli S, Pawlita M, Holzinger D. Evaluation of type-specific antibodies to high risk-human papillomavirus (HPV) proteins in patients with oropharyngeal cancer. Oral Oncol 2017; 70:43-50.
25.05.2017Evaluation of type-specific antibodies to high risk-human papillomavirus (HPV) proteins in patients with oropharyngeal cancer
25.05.2017Oral Oncol 2017; 70:43-50
Broglie Däppen Martina, Jochum Wolfram, Michel Angelika, Waterboer Tim, Foerbs Diana, Schoenegg René, Stöckli Sandro, Pawlita Michael, Holzinger Dana
Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study
Bertisch B, Clifford G, Stöckle M, Cavassini M, Calmy A, Wandeler G, Kovari H, Pawlita M, ess s, Jundt G, Levi F, Dehler S, Bouchardy C, Schöni-Affolter F, Keiser O, Vernazza P, Lise M, Franceschi S, Swiss HIV Cohort Study Investigators. Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study. Am J Epidemiol 2013; 178:877-84.
30.07.2013Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study
30.07.2013Am J Epidemiol 2013; 178:877-84
Bertisch Barbara, Clifford Gary, Stöckle Marcel, Cavassini Matthias, Calmy Alexandra, Wandeler Gilles, Kovari Helen, Pawlita Michael, ess silvia, Jundt Gernot, Levi Fabio, Dehler Silvia, Bouchardy Christine, Schöni-Affolter Franziska, Keiser Olivia, Vernazza Pietro, Lise Mauro, Franceschi Silvia, Swiss HIV Cohort Study Investigators
Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation
Broglie Däppen M, Soltermann A, Rohrbach D, Haile S, Pawlita M, Studer G, Huber G, Moch H, Stöckli S. Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation. Head & neck 2013; 35:1698-706.
18.03.2013Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation
18.03.2013Head & neck 2013; 35:1698-706
Broglie Däppen Martina, Soltermann Alex, Rohrbach David, Haile Sarah R, Pawlita Michael, Studer Gabriela, Huber Gerard F, Moch Holger, Stöckli Sandro